Patients should be advised to seek prompt medical evaluation for severe or persistent gastrointestinal symptoms, vision changes, unusual neck swelling or hoarseness, or severe constipation with abdominal distention
In the landmark STEP 1 clinical trial, patients lost an average of 14.9% of body weight over 68 weeks compared to 2.4% with placebo
Improved glycemic control with once-weekly dulaglutide in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring
Koppenol WH, Bounds PL, Dang CV
Wu W, Li W, Chen H, Jiang L, Zhu R, Feng D
Our complete formula helps you manage hunger, support metabolism, and maintain digestive health WITHOUT any side effects for enhanced well-being